Literature DB >> 16707500

Interferon regulatory factor 8 regulates RANTES gene transcription in cooperation with interferon regulatory factor-1, NF-kappaB, and PU.1.

Jianguo Liu1, Xiaojing Ma.   

Abstract

Interferon regulatory factor (IRF)-8 is a member of the IRF family of transcription factors important in interferon-gamma-mediated signaling and in the development and function of dendritic cells. Regulated on activation, normal T cell expressed and secreted (RANTES, or CCL5) is a member of the CC chemokine family of proteins, strongly chemoattractant for several important immune cell types in host defense against infectious agents and cancer. Here we report that RANTES expression in IRF-8-null macrophages stimulated with interferon-gamma and lipopolysaccharide is markedly decreased. IRF-8 can activate RANTES gene transcription in synergism with IRF-1. Interestingly, IRF-8 can activate RANTES transcription independently of IRF-1 through direct physical interactions with NF-kappaB c-Rel and PU.1 via the NF-kappaB element located at -88 to -79 in vitro and in vivo. This study uncovers a novel role of IRF-8 in the regulation of RANTES gene expression and the underlying molecular mechanisms whereby IRF-8 interacts with several other important transcription factors to initiate innate immune responses to pathogenic and inflammatory challenges by activating the RANTES gene.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16707500     DOI: 10.1074/jbc.M602059200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  27 in total

1.  Suppression of IL-12 production by tristetraprolin through blocking NF-kcyB nuclear translocation.

Authors:  Ling Gu; Huan Ning; Xuesong Qian; Qi Huang; Rong Hou; Rajaa Almourani; Mingui Fu; Perry J Blackshear; Jianguo Liu
Journal:  J Immunol       Date:  2013-08-30       Impact factor: 5.422

2.  Tumor-secreted PGE2 inhibits CCL5 production in activated macrophages through cAMP/PKA signaling pathway.

Authors:  Xuesong Qian; Jidong Zhang; Jianguo Liu
Journal:  J Biol Chem       Date:  2010-11-19       Impact factor: 5.157

Review 3.  Transcription factors in the control of dendritic cell life cycle.

Authors:  Arpita S Bharadwaj; Devendra K Agrawal
Journal:  Immunol Res       Date:  2007       Impact factor: 2.829

4.  Activation of IL-27 p28 gene transcription by interferon regulatory factor 8 in cooperation with interferon regulatory factor 1.

Authors:  Jidong Zhang; Xuesong Qian; Huan Ning; Jianjun Yang; Huabao Xiong; Jianguo Liu
Journal:  J Biol Chem       Date:  2010-04-30       Impact factor: 5.157

5.  The c-Rel Transcription Factor in Development and Disease.

Authors:  Thomas D Gilmore; Steve Gerondakis
Journal:  Genes Cancer       Date:  2011-07

Review 6.  Tumor-induced myeloid dysfunction and its implications for cancer immunotherapy.

Authors:  Michelle N Messmer; Colleen S Netherby; Debarati Banik; Scott I Abrams
Journal:  Cancer Immunol Immunother       Date:  2014-11-29       Impact factor: 6.968

7.  The cell-specific induction of CXC chemokine ligand 9 mediated by IFN-gamma in microglia of the central nervous system is determined by the myeloid transcription factor PU.1.

Authors:  Sally L Ellis; Vanessa Gysbers; Peter M Manders; Wen Li; Markus J Hofer; Marcus Müller; Iain L Campbell
Journal:  J Immunol       Date:  2010-06-28       Impact factor: 5.422

8.  Dynamic protein associations define two phases of IL-1beta transcriptional activation.

Authors:  Yue Zhang; Simona Saccani; Hyunjin Shin; Barbara S Nikolajczyk
Journal:  J Immunol       Date:  2008-07-01       Impact factor: 5.422

9.  The Fli-1 transcription factor regulates the expression of CCL5/RANTES.

Authors:  Mara L Lennard Richard; Shuzo Sato; Eiji Suzuki; Sarah Williams; Tamara K Nowling; Xian K Zhang
Journal:  J Immunol       Date:  2014-08-06       Impact factor: 5.422

Review 10.  A multi-functional role of interferon regulatory factor-8 in solid tumor and myeloid cell biology.

Authors:  Scott I Abrams
Journal:  Immunol Res       Date:  2010-03       Impact factor: 2.829

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.